“This acquisition adds not only to our commercial portfolio and reinforces our leading position in travel vaccines, but it also strengthens our pipeline with a promising late-stage vaccine candidate ...
Dublin, March 13, 2026 (GLOBE NEWSWIRE)-- The "Vaxchora Market Report 2026: Epidemiology, Pipeline Analysis, Market Insights & Forecasts" has been added to ResearchAndMarkets.com's offering. Recent ...
COPENHAGEN, Denmark, March 12, 2026 - Bavarian Nordic A/S (OMX: BAVA) today published its annual report for 2025. The consolidated, audited results were in line with the preliminary results announced ...
Bavarian Nordic CEO Paul Chaplin will step down by the end of 2026 after overseeing the company’s transformation into a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results